These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29172528)

  • 61. Synthesis and evaluation of new 5-aminolevulinic acid derivatives as prodrugs of protoporphyrin for photodynamic therapy.
    Zhu W; Gao YH; Song CH; Lu ZB; Namulinda T; Han YP; Yan YJ; Wang LX; Chen ZL
    Photochem Photobiol Sci; 2017 Nov; 16(11):1623-1630. PubMed ID: 28933502
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
    Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
    J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A Molecular Hybrid for Mitochondria-Targeted NO Photodelivery.
    Sodano F; Gazzano E; Fraix A; Rolando B; Lazzarato L; Russo M; Blangetti M; Riganti C; Fruttero R; Gasco A; Sortino S
    ChemMedChem; 2018 Jan; 13(1):87-96. PubMed ID: 29110418
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Targeted diazeniumdiolates: localized nitric oxide release from glioma-specific peptides and proteins.
    Safdar S; Taite LJ
    Int J Pharm; 2012 Jan; 422(1-2):264-70. PubMed ID: 22101282
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nitric oxide donor hybrid compounds as promising anticancer agents.
    Ding QG; Zang J; Gao S; Gao Q; Duan W; Li X; Xu W; Zhang Y
    Drug Discov Ther; 2017 Jan; 10(6):276-284. PubMed ID: 27990006
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Novel highly potent and selective sigma 1 receptor antagonists related to spipethiane.
    Piergentili A; Amantini C; Del Bello F; Giannella M; Mattioli L; Palmery M; Perfumi M; Pigini M; Santoni G; Tucci P; Zotti M; Quaglia W
    J Med Chem; 2010 Feb; 53(3):1261-9. PubMed ID: 20067271
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antiproliferative activity and apoptosis inducing effects of nitric oxide donating derivatives of evodiamine.
    Zhao N; Tian KT; Cheng KG; Han T; Hu X; Li DH; Li ZL; Hua HM
    Bioorg Med Chem; 2016 Jul; 24(13):2971-2978. PubMed ID: 27178387
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Applications for nitric oxide in halting proliferation of tumor cells.
    Reynolds MM; Witzeling SD; Damodaran VB; Medeiros TN; Knodle RD; Edwards MA; Lookian PP; Brown MA
    Biochem Biophys Res Commun; 2013 Feb; 431(4):647-51. PubMed ID: 23337501
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Growth inhibition and chemosensitization of exogenous nitric oxide released from NONOates in glioma cells in vitro.
    Weyerbrock A; Baumer B; Papazoglou A
    J Neurosurg; 2009 Jan; 110(1):128-36. PubMed ID: 18991497
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cytotoxic and pro-oxidant profile of a photosensitive ruthenium nitrosyl candidate for NO delivery in healthy human fibroblasts.
    Özbaşak H; Elbeheiry HM; Schulz M; Račková L
    Gen Physiol Biophys; 2024 Sep; 43(5):469-484. PubMed ID: 39140687
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Evolution of the Sigma-2 (σ
    Zeng C; Mach RH
    Adv Exp Med Biol; 2017; 964():49-61. PubMed ID: 28315264
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Small molecules for great solutions: Can nitric oxide-releasing nanomaterials overcome drug resistance in chemotherapy?
    Pieretti JC; Pelegrino MT; Nascimento MHM; Tortella GR; Rubilar O; Seabra AB
    Biochem Pharmacol; 2020 Jun; 176():113740. PubMed ID: 31786262
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Sensitization of ruthenium nitrosyls to visible light via direct coordination of the dye resorufin: trackable NO donors for light-triggered NO delivery to cellular targets.
    Rose MJ; Fry NL; Marlow R; Hinck L; Mascharak PK
    J Am Chem Soc; 2008 Jul; 130(27):8834-46. PubMed ID: 18597437
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synthesis and receptor binding studies of some new arylcarboxamide derivatives as sigma-1 ligands.
    Zampieri D; Laurini E; Vio L; Golob S; Fermeglia M; Pricl S; Mamolo MG
    Bioorg Med Chem Lett; 2014 Feb; 24(4):1021-5. PubMed ID: 24486131
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Decahydrobenzoquinolin-5-one sigma receptor ligands: Divergent development of both sigma 1 and sigma 2 receptor selective examples.
    McLeod MC; Aubé J; Frankowski KJ
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5689-5694. PubMed ID: 27839919
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antiproliferative effects of ZnO, ZnO-MTCP, and ZnO-CuMTCP nanoparticles with safe intensity UV and X-ray irradiation.
    Sadjadpour S; Safarian S; Zargar SJ; Sheibani N
    Biotechnol Appl Biochem; 2016; 63(1):113-24. PubMed ID: 25581219
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors.
    El-Sherief HAM; Youssif BGM; Abbas Bukhari SN; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
    Eur J Med Chem; 2018 Aug; 156():774-789. PubMed ID: 30055463
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Novel 1-(2-aryl-2-adamantyl)piperazine derivatives with antiproliferative activity.
    Fytas C; Zoidis G; Tsotinis A; Fytas G; Khan MA; Akhtar S; Rahman KM; Thurston DE
    Eur J Med Chem; 2015 Mar; 93():281-90. PubMed ID: 25703296
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Androgen Receptor Targeted Conjugate for Bimodal Photodynamic Therapy of Prostate Cancer in Vitro.
    Rapozzi V; Ragno D; Guerrini A; Ferroni C; della Pietra E; Cesselli D; Castoria G; Di Donato M; Saracino E; Benfenati V; Varchi G
    Bioconjug Chem; 2015 Aug; 26(8):1662-71. PubMed ID: 26108715
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Magneto low-density nanoemulsion (MLDE): A potential vehicle for combined hyperthermia and photodynamic therapy to treat cancer selectively.
    Pellosi DS; Macaroff PP; Morais PC; Tedesco AC
    Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():103-111. PubMed ID: 30184726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.